tadalafil has been researched along with technetium tc 99m exametazime in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (technetium tc 99m exametazime) | Trials (technetium tc 99m exametazime) | Recent Studies (post-2010) (technetium tc 99m exametazime) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 2,986 | 259 | 198 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lampl, Y; Lorberboym, M; Makhline, E | 1 |
1 trial(s) available for tadalafil and technetium tc 99m exametazime
| Article | Year |
|---|---|
Regional cerebral blood flow following single-dose and continuous-dose tadalafil after stroke.
Topics: Adult; Aged; Carbolines; Cerebrovascular Circulation; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Radiopharmaceuticals; Stroke; Tadalafil; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2014 |